Compositions and methods for nucleic acid modifications
AssigneeAcrigen Biosciences
InventorsDavid Rabuka, Michael Schelle, Allison Sharrar
Life of this patent
Estimating the term…
Abstract
The present disclosure provides nucleases and compositions, methods, and systems thereof for nucleic acid modification. More particularly, the present disclosure provides compositions and system comprising a nuclease comprising an amino acid sequence having at least 70% identity to any of SEQ ID NOs: 1-250 and at least one gRNA for target nucleic acid modification.
Claims85
A composition comprising a nuclease, wherein the nuclease comprises a sequence with at least 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or with at least 99% identity to any one of SEQ ID NOs:
- 1-250.
A system for modifying a target nucleic acid comprising:
- a) a nuclease comprising an amino acid sequence having at least 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% identity or 100% identity to any of SEQ ID NOs:
- 1-250 or a nucleic acid encoding the nuclease;
- and
- b) at least one guide RNA (gRNA) comprising a sequence complementary to at least a portion of a target nucleic acid and a region that associates with the nuclease, or a nucleic acid encoding the at least one gRNA.
Dependencies are inferred from the claim text.